Drug Type siRNA |
Synonyms BP-100-2.01, BP-101-2.01 |
Target |
Action inhibitors |
Mechanism PTK2b gene inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Discovery | United States | - | |
| Ovarian Cancer | Discovery | United States | - | |
| Thyroid Cancer | Discovery | United States | - |





